The drug maker Eli Lilly saw an 8% surge in its stock after reporting second-quarter earnings that exceeded expectations. This surge was attributed to the outstanding performance of its blockbuster diabetes drug Mounjaro and weight loss injection Zepbound. The company also raised its full-year revenue outlook by $3 billion, indicating strong growth potential in the
0 Comments
In recent years, Disney’s media business has faced scrutiny due to losses in streaming combined with a decline in traditional pay TV. However, the tables seem to have turned with the company’s second-quarter results indicating a positive shift. The combined streaming services of Disney — Disney+, Hulu, and ESPN+ — made a quarterly profit of
0 Comments